All Stories

  1. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma

    Article • Cell Cycle, July 2018, Taylor & Francis

    Antonio Cigliano

  2. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis

    Article • Hepatology, May 2017, Wiley

    Antonio Cigliano

  3. Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice

    Article • Oncotarget, April 2017, Impact Journals, LLC

    Antonio Cigliano

  4. Role of the Notch signaling in cholangiocarcinoma

    Article • Expert Opinion on Therapeutic Targets, March 2017, Taylor & Francis

    Antonio Cigliano

  5. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma

    Article • Cell Cycle, January 2017, Taylor & Francis

    Antonio Cigliano

  6. Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans

    Article • Oncogenesis, December 2016, Nature

    Antonio Cigliano

  7. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models

    Article • International Journal of Molecular Sciences, September 2016, MDPI AG

    Antonio Cigliano

  8. Bothde novosynthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells

    Article • Liver International, July 2016, Wiley

    Antonio Cigliano

  9. Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique

    Article • Journal of Magnetic Resonance Imaging, May 2016, Wiley

    Antonio Cigliano

  10. Differential requirement forde novolipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans

    Article • Hepatology, March 2016, Wiley

    Antonio Cigliano

  11. Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice

    Article • Scientific Reports, February 2016, Nature

    Antonio Cigliano

  12. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans

    Article • Journal of Hepatology, February 2016, Elsevier

    Antonio Cigliano

  13. PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells

    Article • Hepatology, January 2016, Wiley

    Antonio Cigliano

  14. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice

    Article • Seminars in Musculoskeletal Radiology, December 2015, Thieme Publishing Group

    Antonio Cigliano

  15. Different oncogenic potential in the mouse liver of mutant forms of the p110alpha catalytic subunit of phosphoinositide-3-kinase (PIK3CA)

    Article • Seminars in Musculoskeletal Radiology, December 2015, Thieme Publishing Group

    Antonio Cigliano

  16. Molekulare und metabolische Veränderungen in humanen klarzelligen Leberherden

    Article • Der Pathologe, October 2015, Springer Science + Business Media

    Antonio Cigliano

  17. PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men

    Article • Oncotarget, June 2015, Impact Journals, LLC

    Antonio Cigliano

  18. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver

    Article • Oncotarget, May 2015, Impact Journals, LLC

    Antonio Cigliano

  19. SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice

    Article • Oncotarget, February 2015, Impact Journals, LLC

    Antonio Cigliano

  20. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes in mice

    Article • Seminars in Musculoskeletal Radiology, January 2015, Thieme Publishing Group

    Antonio Cigliano

  21. SKP2 cooperates with N-Ras or AKT to induce liver tumor development in the mouse

    Article • Seminars in Musculoskeletal Radiology, January 2015, Thieme Publishing Group

    Antonio Cigliano

  22. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice

    Article • Hepatology, November 2014, Wiley

    Antonio Cigliano

  23. Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice

    Article • Gastroenterology, September 2014, Elsevier

    Antonio Cigliano

  24. Synergistische Effekte von Beta-Catenin und YAP führen zur Entstehung von Hepatoblastomen in Mäusen und beim Menschen

    Article • Seminars in Musculoskeletal Radiology, January 2014, Thieme Publishing Group

    Antonio Cigliano

  25. Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: Implications for the treatment of human liver cancer

    Article • Cell Cycle, July 2013, Taylor & Francis

    Antonio Cigliano

  26. Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis

    Article • Journal of Hepatology, June 2013, Elsevier

    Antonio Cigliano

  27. Complete inhibition of mTORC1 cascade is required to suppress hepatocarcinogenesis induced by AKT and Ras co-expression

    Article • Seminars in Musculoskeletal Radiology, January 2013, Thieme Publishing Group

    Antonio Cigliano

  28. Clear cell foci of altered hepatocytes and hepatocellular carcinomas in the N-Nitrosomorpholine (NNM) model in the rat show an overexpression of pro-oncogenic pathways and metabolic alterations similar to lesions in the islet-transplantation model

    Article • Seminars in Musculoskeletal Radiology, January 2013, Thieme Publishing Group

    Antonio Cigliano

  29. Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways

    Article • Journal of Hepatology, September 2012, Elsevier

    Antonio Cigliano

  30. Association between Human Plasma Chondroitin Sulfate Isomers and Carotid Atherosclerotic Plaques

    Article • Biochemistry Research International, January 2012, Hindawi Publishing Corporation

    Antonio Cigliano

  31. Fine Structure of Glycosaminoglycans from Fresh and Decellularized Porcine Cardiac Valves and Pericardium

    Article • Biochemistry Research International, January 2012, Hindawi Publishing Corporation

    Antonio Cigliano

  32. Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair

    Article • Cell, July 2011, Elsevier

    Antonio Cigliano

  33. 73 APOLIPOPROTEIN PROFILES IN ATHEROSCLEROTIC DISEASE

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Antonio Cigliano

  34. Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal

    Article • Acta Biomaterialia, December 2010, Elsevier

    Antonio Cigliano

  35. Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles

    Article • Archives of Gynecology and Obstetrics, March 2010, Springer Science + Business Media

    Antonio Cigliano, Professor of Gynecology and Obstetrics, M.D., Ph.D. GIAMPIERO CAPOBIANCO

  36. Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts

    Article • Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, January 2010, PAGEPress Publications

    Antonio Cigliano

  37. Glycosaminoglycans and Fabry's disease

    Article • Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, January 2010, PAGEPress Publications

    Antonio Cigliano

  38. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries

    Article • Atherosclerosis, March 2009, Elsevier

    Antonio Cigliano